What are the possible causes of an elevated red blood cell count with normal hemoglobin, normal mean corpuscular volume (MCV), and normal hematocrit?

Elevated RBC Count with Normal Hemoglobin, MCV, and Hematocrit

This unusual pattern most likely represents either a laboratory artifact/spurious result or masked polycythemia vera (PV), and you should immediately order JAK2 mutation testing while investigating for technical errors. 1

Primary Diagnostic Considerations

Laboratory Artifact (Most Common)

The combination of elevated RBC count with normal hemoglobin and hematocrit is physiologically inconsistent and strongly suggests a spurious result 2. Common technical causes include:

• RBC agglutination from cold agglutinins or EDTA-dependent antibodies
• Platelet clumping falsely counted as small RBCs
• Lipemia interfering with optical measurements
• Cryoglobulins affecting cell counting
• Insufficient sample mixing before analysis

Critical pitfall: Always verify the mean corpuscular hemoglobin concentration (MCHC). If MCHC is abnormally low or high, this confirms a spurious result requiring sample recollection and reanalysis 3.

Masked Polycythemia Vera (Most Important Pathologic Cause)

A subset of JAK2-positive PV patients present with normal hemoglobin and hematocrit despite elevated RBC counts 1. This occurs due to:

• Concurrent iron deficiency masking the elevated hemoglobin
• Blood volume expansion diluting the hemoglobin concentration
• Recent blood loss (occult or overt)

The 2015 WHO diagnostic criteria for PV require hemoglobin >18.5 g/dL (men) or >16.5 g/dL (women) as a major criterion 4. However, masked PV represents an important exception where JAK2 mutations are present before overt polycythemia develops.

Diagnostic Algorithm

1. First: Rule out spurious results

   • Check MCHC (should be 32-36 g/dL)
   • Review blood smear for RBC agglutination or platelet clumping
   • Recollect sample if any abnormalities detected 2

2. If RBC elevation persists: Order JAK2V617F mutation testing

   • Particularly critical if patient has history of thrombosis (especially unusual sites like portal vein, hepatic vein, or splenic vein) 1
   • Check for splenomegaly on physical exam
   • Measure serum erythropoietin level (will be subnormal in PV) 5, 4

3. If JAK2 positive: Proceed with bone marrow biopsy

   • Look for hypercellularity with trilineage proliferation
   • This confirms PV diagnosis even with normal hemoglobin 5, 4

4. Check iron studies

   • Ferritin, serum iron, TIBC, transferrin saturation
   • Iron deficiency commonly masks PV 5
   • After iron repletion, hemoglobin may rise to diagnostic PV levels 6

Secondary Considerations

Polycythemia with Iron Deficiency

Secondary polycythemia (from hypoxia, smoking, sleep apnea, high altitude, or renal tumors) combined with iron deficiency can produce microcytic polycythemia 6. However, your scenario specifies normal MCV, making this less likely unless iron deficiency is very mild.

Hereditary Hemochromatosis

While HH causes elevated RBC counts, it characteristically presents with elevated hemoglobin levels, not normal hemoglobin 7. This diagnosis is inconsistent with your presentation.

Clinical Significance

The prognosis of masked PV is poor, particularly in older patients with leukocytosis 1. These patients have the same thrombotic risk as overt PV despite normal blood counts. Missing this diagnosis can result in life-threatening thrombotic complications.

Key action point: Any patient with unexplained thrombosis (especially splanchnic vein thrombosis) should undergo JAK2 testing regardless of normal hemoglobin or hematocrit 1.

Management Implications

If masked PV is confirmed:

• Initiate aspirin for thrombosis prevention
• Consider phlebotomy once iron deficiency is corrected and hemoglobin rises
• Monitor for progression to overt PV
• Risk-stratify for cytoreductive therapy based on age >60 years and thrombosis history 4

5412